Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | YWHAG | P61981 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23425343 | 0.87 | MEN1 (0.37) | HSD17B10MEN1USP2POLBHSP90AA1 | |
| SCHEMBL18934462 | 0.86 | MEN1 (0.31) | HSD17B10MEN1USP2POLBHSP90AA1 | |
| SCHEMBL22193121 | 0.83 | HSD17B10 (0.47) | HSD17B10MEN1USP2POLBHSP90AA1 | |
| SCHEMBL20887111 | 0.83 | MEN1 (0.34) | HSD17B10MEN1USP2POLBHSP90AA1 | |
| SCHEMBL14005740 | 0.79 | HSD17B10 (0.35) | HSD17B10MEN1USP2POLBHSP90AA1 | |
| SCHEMBL12515075 | 0.78 | CA1 (0.34) | — | |
| SCHEMBL12515067 | 0.78 | CA1 (0.33) | HSD17B10MEN1USP2POLBHSP90AA1 | |
| SCHEMBL18874779 | 0.77 | HSD17B1 (0.30) | — | |
| SCHEMBL21319383 | 0.76 | F2 (0.32) | — | |
| SCHEMBL23683711 | 0.75 | MEN1 (0.31) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200353089-A1 | POLYMERS WITH RIGID SPACING GROUPS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | Sony Group Corporation (JP) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200353089-A1 | POLYMERS WITH RIGID SPACING GROUPS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | MRPL21, TLN1, L3MBTL1 | HSD17B10 4471/4885MEN1 402/4885USP2 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.